• No se han encontrado resultados

Daclatasvir and Peginterferon/Ribavirin for Black/African American and Latino Patients with HCV infection

N/A
N/A
Protected

Academic year: 2020

Share "Daclatasvir and Peginterferon/Ribavirin for Black/African American and Latino Patients with HCV infection"

Copied!
12
0
0

Texto completo

Loading

Figure

Table 1. Baseline demographics and disease characteristics.
Figure 1. Patients with SVR12, according to cohort. Historical rate of SVR for the black/AA cohort (26% [solid line]) and Latino cohort (36% [dashed line])
Figure 2. On-treatment mean HCV-RNA levels over time: black/AA and Latino cohorts.
Table 3. SVR12 (mITT) by subgroup.
+2

Referencias

Documento similar

 The expansionary monetary policy measures have had a negative impact on net interest margins both via the reduction in interest rates and –less powerfully- the flattening of the

This study assesses the number of patients treated with the antithrombotics traditionally available for stroke prevention in non-valvular AF and the clinical

Sources of data for analysis included study-level data from the Cohorts for Heart and Aging Research in Genomic Epidemiology Birth Gene (CHARGE-BIG) Study (49 studies, n = 180

This study first demonstrates that plasma levels of mt- DNA and n-DNA, and those of H-FABP and Tn-I, were significantly higher in patients with massive PE compared with those

This study evaluated the usefulness of baseline FibroScan values for predicting SVR and the occurrence of anemia and other severe adverse events in HCV genotype 1 patients with

We have studied the characteristics of HCV-nAbs through a retrospective study involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with peg-

The efficiency-corrected WIMP-search energy spectrum is shown in keV nr and compared with expected rates for WIMPs with the most likely masses and cross sections suggested by

In conclusion, the results of this study analyzing treatment outcomes for LDV/SOF against HCV genotype 1 in treatment- naïve noncirrhotic patients suggest that HIV infection is a